First Quarter 2018 Financial Results. January 26, 2018
|
|
- Lucinda Gregory
- 5 years ago
- Views:
Transcription
1 First Quarter 2018 Financial Results January 26, 2018
2 This presentation contains forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of All statements included herein that are not historical facts are forwardlooking statements, including without limitation statements regarding Hill-Rom s ability to drive sustainable profitable growth and shareholder value, the timing and success of new product launches and portfolio expansion, the ability to achieve the anticipated benefits of the Mortara acquisition, the achievement of long-range financial objectives, the continuation of stable customer demand trends, a stable U.S. capital environment, the timing and success of M&A and optimization initiatives, our ability to reduce debt, the impact of the new U.S. tax reform legislation, and all other statements concerning future strategy, plans, objectives, projections, expectations and intentions. Such forward-looking statements involve a number of risks and uncertainties and are subject to change at any time. In the event such risks or uncertainties materialize, Hill-Rom s results could be materially adversely affected. For a more in depth discussion of factors that could cause actual results to differ from those contained in forward-looking statements, see the discussions under the heading Risk Factors in the company's previously filed most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q. Hill-Rom assumes no obligation to update or revise any forward-looking statements. Certain financial figures presented herein have been presented on an adjusted basis (non-gaap). Reconciliation between non-gaap financial measures and reported U.S. GAAP measures are included in the appendices to this slide deck. Page 2
3 Page 3
4 Q Highlights
5 Leadership $2.7B global medical technology leader with market-leading positions 2017 Revenue by Business US$ Billions Surgical Solutions Front Line Care $2.7B FY 2017 Patient Support Systems Note: Hill-Rom fiscal year end is September 30 Innovation Advancing global scale and brand equity while enhancing outcomes Increased Investment in R&D US$ Millions 4.6% of revenue $92 4.9% of revenue $ Value Transforming to drive sustainable profitable growth and shareholder value Key Valuation Metrics As of 12/31/2017 $5.5B $7.6B +51% $97M Market Capitalization Enterprise Value LTM Total Shareholder Return Fiscal 2017 Returned to Shareholders* *Includes dividends and share repurchases Page 5
6 Accelerating growth by advancing strong brands and geographic footprint Driving commercial momentum and operational execution with Q1 core revenue* growth of 2% Establishing a diversified business to drive sustainable growth and profitability Innovating to enhance outcomes for patients and their caregivers Launching Centrella Smart+ bed in the U.S. and Canada, optimizing safety, satisfaction and efficiency; and TruSystem 7500 MR Neuro Surgical Table, for better patient treatment and surgical workflow Capitalizing on significant introductions such as Integrated Table Motion, Connex Spot Monitor, RetinaVue and Spot Vision Screener Transforming the portfolio with select M&A and optimization initiatives Integrating Mortara, driving accretive gross margin and realizing synergy benefits Optimizing product portfolio through completed divestitures and exit of non-strategic assets Driving operational execution and strong financial performance Delivering solid revenue growth, expanding margins and growing adjusted EPS by 23% to $0.92 Increasing full-year adjusted EPS guidance to $4.57 to $4.65 per diluted share, including positive contribution from new U.S. tax reform legislation of $0.30 per diluted share Enhancing Shareholder Value By Executing Our Strategy Page 6 Note: Adjusted gross margin, operating margin and EPS are non-gaap measures. See reconciliation to reported GAAP numbers in the appendix to this presentation *Core revenue excludes foreign currency, divestitures, exit of nonstrategic assets (third-party rental and third-party surfaces), and Mortara
7 Q Financial Summary
8 Revenue Operating Margin Earnings Per Share Operating Cash Flow 2% Core* Growth +10 BPS +23% Growth +31% Growth $670M 14.6% 14.7% $0.75 $0.92 $71M $93M $637M Q Q Q Q Q Q Q Q Exceeding Q Revenue and Adjusted EPS Guidance Page 8 Note: Adjusted gross margin, operating margin and EPS are non-gaap measures. See reconciliation to reported GAAP numbers in the appendix to this presentation; Axis not to scale; *Core revenue excludes foreign currency, divestitures, exit of non-strategic assets (third-party rental and third-party surfaces), and Mortara
9 Fiscal First Quarter Adjusted P&L YOY Change Revenue $637M $670M +3% constant currency +2% core growth* Gross Margin 47.5% 47.7% +20 bps Operating Margin 14.6% 14.7% +10 bps Adjusted EPS $0.75 $ % Driving 10 th Consecutive Quarter Of Double-Digit Adjusted EPS Growth Page 9 Note: Adjusted gross margin, operating margin and EPS are non-gaap measures. See reconciliation to reported GAAP numbers in the appendix to this presentation *Core revenue excludes foreign currency, divestitures, exit of non-strategic assets (third-party rental and third-party surfaces), and Mortara
10 Patient Support Systems Front Line Care Surgical Solutions Q Q Q Building momentum with new products like Centrella, Envella and Accella Growing U.S. core bed portfolio MSD Improving international trends in Middle East, Europe and Canada Accelerating exit of lowmargin third-party rental and third-party surfaces Capitalizing on recent product introductions Growing thermometry, blood pressure and physical assessment revenue Delivering strong core international growth with One Hill-Rom approach Driving 10%+ growth in Respiratory Care Exceeding expectations with Integrated Table Motion adoption Continuing strong international growth Introducing new TruSystem 7500 MR Neuro Surgical Table Advancing innovation and partnerships to drive future growth Note: All revenue growth rates are constant currency *Core revenue excludes foreign currency, divestitures, exit of non-strategic assets (third-party rental and third-party surfaces), and Mortara Page 10
11 Adjusted Gross Margin Adjusted Operating Margin +90 bps +20 bps (70) bps 47.5% 47.7% (10) bps 14.6% 14.7% Q Mix Surgical & Rental* Q Q GM Expansion Opex Leverage Q bps Gross Margin Expansion +10 bps Operating Margin Expansion Offsetting Temporary Margin Headwinds With New Products, Portfolio Diversification And Ongoing Optimization Initiatives Note: Adjusted gross margin, operating margin and EPS are non-gaap measures. See reconciliation to reported GAAP numbers in the appendix to this presentation; Axis not to scale *Includes impact from hurricane related expenses Page 11
12 Solid core revenue* growth of 2% Offsetting temporary headwinds with margin improvement from new products and portfolio optimization Strategic investments within R&D and SG&A to drive future growth Positive benefit from new U.S. tax reform legislation, resulting in benefit of $0.06 per diluted share Adjusted EPS Growth US$ $ % growth $0.92 $0.92 Adjusted Earnings Per Diluted Share Q Q Exceeding Expectations With 23% Adjusted EPS Growth Page 12 Note: Adjusted gross margin, operating margin and EPS are non-gaap measures. See reconciliation to reported GAAP numbers in the appendix to this presentation *Core revenue growth excludes foreign currency, divestitures, exit of non-strategic assets (third-party rental and third-party surfaces), and Mortara
13 Strong Cash Flow Generation US$ Millions $71 $93 Operating Cash Flow $49 Q Q $66 Free Cash Flow +31% Growth Q Operating Cash Flow Capital Allocation Priorities Reducing debt levels Re-investing in business (R&D and CapEx) Delivering quarterly dividend Executing disciplined M&A strategy emphasizing: Accelerated growth with diversified revenue streams and accretive P&L profile Products and services that strengthen clinical and economic value with customers ~4.0x ~3.2x* 2017 Leverage 2018 Leverage Enhancing Financial Flexibility With Strong Cash Flow Generation Note: Leverage calculated as Total Debt divided by EBITDA as defined in Hill-Rom s compliance certificate *Assumes no further M&A activity Page 13
14 2018 Financial Outlook
15 ~3% Core Revenue Growth* ~100 bps Operating Margin Expansion 18% - 20% Growth in Adjusted EPS Adjusted P&L 2018 Outlook Prior 2018 Outlook Current Revenue Growth (reported) 3% - 4% 3% - 4% Gross Margin +50 bps +50 bps Operating Margin +100 bps +100 bps Adjusted EPS $ $4.30 $ $4.65 Operating Cash Flow $330M - $340M ~$350M Capital Expenditures ~$110M ~$110M Raising 2018 Adjusted EPS And Cash Flow Guidance Page 15 Note: Adjusted gross margin, operating margin and EPS are non-gaap measures. See reconciliation to reported GAAP numbers in the appendix to this presentation; *Core revenue excludes foreign currency, divestitures, exit of non-strategic assets (third-party rental and third-party surfaces), and Mortara prior to the anniversary date of the acquisition
16 2018 Revenue Growth Outlook 2018 Revenue Growth Constant Core* Patient Support Systems ~Flat Low-Single Digits ~3% 3% - 4% Front Line Care High-Single Digits Low-to-Mid Single Digits 2% - 3% Surgical Solutions Low-to-Mid Single Digits Total Hill-Rom 2% - 3% ~3% Core Revenue* Mortara Non-Strategic Constant Currency FX Reported Revenue Delivering Solid 2018 Core Revenue Growth Of ~3% Page 16 Note: All growth rates are constant currency *Core revenue excludes foreign currency, divestitures, exit of nonstrategic assets (third-party rental and third-party surfaces), and Mortara prior to the anniversary date of the acquisition
17 Adjusted P&L Q Outlook Q Outlook Reflects: Continuing core momentum and benefit from new products Annualizing Mortara acquisition Revenue Growth ~4% Reported Anticipating higher margins: Higher revenue Revenue Growth ~2% Constant ~ 2% Core* Improved surgical margins Mortara synergy benefits Adjusted EPS $ $1.02 Cost and business optimization initiatives savings Solid Revenue Growth And Operating Leverage Driving Adjusted EPS Growth *Core revenue excludes foreign currency, divestitures, exit of non-strategic assets (third-party rental and third-party surfaces), and Mortara prior to the anniversary date of the acquisition Page 17
18 2020 Long-Range Plan Update (Updated For Benefit Of New U.S. Tax Reform Legislation)
19 4% - 5% Core Revenue Growth* 300+ bps Operating Margin Expansion 12% - 14% Growth in Adjusted EPS Adjusted P&L 2020 Outlook Prior 2020 Outlook Current Revenue Growth (constant) 3% - 4% CAGR 3% - 4% CAGR Gross Margin ~50% ~50% Operating Margin 19% - 20% 19% - 20% Adjusted EPS Growth 10% - 12% CAGR 12% - 14% CAGR Operating Cash Flow Capital Expenditures $1.1B+ [ ] ~$350M [ ] ~$1.2B [ ] ~$350M [ ] Updating 2020 Outlook To Reflect New U.S. Tax Reform Legislation Note: Adjusted gross margin, operating margin and EPS are non-gaap measures. See reconciliation to reported GAAP numbers in the appendix to this presentation; CAGR calculated ; outlook assumes an effective tax rate of ~24% and diluted shares of ~68 million *Core revenue excludes foreign currency, divestitures and exit of non-strategic assets (third-party rental and third-party surfaces); collectively, 2017 divestitures and non-strategic Page 19 revenue totaled ~$100M
20 Strong Cash Flow Generation US$ ~$1.2B Cumulative Operating Cash Flow ~$350M Cumulative CapEx ~$850M Cumulative Free Cash Flow ~$1.2B Cumulative Operating Cash Flow Capital Allocation Priorities Reducing debt levels Re-investing in business (R&D and CapEx) Increasing dividends Executing disciplined M&A strategy emphasizing: Accelerated growth with diversified revenue streams and accretive P&L profile Products and services that strengthen clinical and economic value with customers <2.5x Leverage by 2020 Enhancing Cash Flow By ~$50M Related To New U.S. Tax Reform Legislation Note: Leverage calculated as Total Debt divided by EBITDA as defined in Hill-Rom s compliance certificate Page 20
21 Revenue Operating Margin Earnings Per Share Operating Cash Flow +4% - 5% Core CAGR* $3.0B BPS 19% - 20% +12% - 14% CAGR $ $ % - 14% CAGR ~$1.2B $3.86 $806M $2.7B+ 16.3% Outlook Outlook Outlook Cumulative Cumulative Outlook Compelling Strategy To Create Value For Shareholders Page 21 Note: Adjusted gross margin, operating margin and EPS are non-gaap measures. See reconciliation to reported GAAP numbers in the appendix to this presentation; Axis not to scale; CAGR calculated ; *Core revenue excludes foreign currency, divestitures and exit of non-strategic assets (third-party rental and third-party surfaces); collectively, 2017 divestitures and non-strategic revenue totaled ~$100M
22 Revenue Schedules
23 Q Q % Actual Rates % Constant Rates United States International Total United States International Total United States International Total United States International Total Patient Support Systems $ $ 90.8 $ $ $ 86.8 $ % 4.6% -0.2% -1.9% -2.0% -1.9% Front Line Care % 22.8% 11.3% 7.1% 17.0% 9.8% Surgical Solutions % 18.6% 10.3% 1.8% 9.7% 5.8% Total Hill-Rom $ $ $ $ $ $ % 13.4% 5.1% 1.5% 6.5% 3.0% Page 23
24 Q Q % Actual Rates % Constant Rates United States International Total United States International Total United States International Total United States International Total Patient Support Systems $ $ 86.8 $ $ $ $ % -13.5% -1.9% 2.9% -10.7% -1.1% Front Line Care % -16.9% -8.4% -4.8% -15.7% -8.0% Surgical Solutions % -8.3% 1.1% 12.9% -4.5% 3.2% Total Hill-Rom $ $ $ $ $ $ % -13.2% -3.6% 1.2% -10.6% -2.7% Q Q % Actual Rates % Constant Rates United States International Total United States International Total United States International Total United States International Total Patient Support Systems $ $ 99.8 $ $ $ 93.8 $ % 6.4% 3.0% 1.8% 9.2% 3.8% Front Line Care % 20.7% 13.9% 11.1% 22.8% 14.5% Surgical Solutions % 8.8% 10.4% 12.2% 12.6% 12.4% Total Hill-Rom $ $ $ $ $ $ % 10.9% 7.3% 5.7% 13.7% 8.2% Q Q % Actual Rates % Constant Rates United States International Total United States International Total United States International Total United States International Total Patient Support Systems $ $ 99.7 $ $ $ $ % -2.5% -1.7% -1.4% -0.2% -1.1% Front Line Care % 20.2% 17.9% 17.0% 23.6% 18.8% Surgical Solutions % 9.4% 5.5% 1.6% 12.4% 7.0% Total Hill-Rom $ $ $ $ $ $ % 6.3% 5.1% 4.6% 9.0% 6.0% Q Q % Actual Rates % Constant Rates United States International Total United States International Total United States International Total United States International Total Patient Support Systems $ $ 97.9 $ $ $ $ % -5.3% -2.9% -2.0% -8.7% -3.8% Front Line Care % 33.9% 16.0% 10.0% 31.8% 15.5% Surgical Solutions % 4.8% 8.6% 12.3% 0.9% 6.6% Total Hill-Rom $ $ $ $ $ $ % 7.1% 4.6% 3.5% 4.0% 3.6% Fiscal Year 2017 Fiscal Year 2016 % Actual Rates % Constant Rates United States International Total United States International Total United States International Total United States International Total Patient Support Systems $ 1,039.7 $ $ 1,423.9 $ 1,037.4 $ $ 1, % -3.9% -0.9% 0.2% -2.8% -0.6% Front Line Care % 12.8% 9.3% 8.0% 14.0% 9.7% Surgical Solutions % 3.4% 6.4% 9.6% 5.0% 7.2% Total Hill-Rom $ 1,887.6 $ $ 2,743.7 $ 1,819.5 $ $ 2, % 2.4% 3.3% 3.7% 3.7% 3.7% Note: Segment revenue by U.S. and International for Fiscal Year ended 9/30/2017 and 9/30/2016 in US$ million; Certain revenue amounts have been reclassified for Surgical Solutions between U.S. and International to more accurately align with the destination of the revenue and to be consistent with the 2018 Page 24 presentation. These changes do not have a significant impact in comparison to previously reported amounts and growth rates
25 Appendix Reconciliations of Non-GAAP Disclosures
26 Quarter Ended December 31 US OUS As Constant As As Constant Reported Currency Reported Reported Currency Product Sales and Service $ $ % 3.8% 2.2% 13.9% 7.0% Rental (1.0%) (1.9%) (1.8%) 4.7% (2.9%) Total $ $ % 3.0% 1.5% 13.4% 6.5% US OUS As Constant As As Constant Reported Currency Reported Reported Currency Patient Support Systems $ $ (0.2%) (1.9%) (1.9%) 4.6% (2.0%) Front Line Care % 9.8% 7.1% 22.8% 17.0% Surgical Solutions % 5.8% 1.8% 18.6% 9.7% Total $ $ % 3.0% 1.5% 13.4% 6.5% Page 26
27 ($ in millions) Quarter Ended December Selling and Administrative Expenses (As Reported) $ $ Acquisition and integration costs (2.4) (6.0) Acquisition-related intangible asset amortization (26.7) (25.5) Litigation settlements and expenses (4.0) - Selling and Administrative Expenses (Adjusted) $ $ Selling and Administrative Expenses (Adjusted) As Percent of Total Revenue 28.2% 27.8% Year Over Year % Change 6.4% Year Over Year Change 40 bps Page 27
28 Gross Margin Quarter Ended December 31, 2017 Income Before Operating Margin 1 Income Taxes Income Tax Expense Diluted EPS 1 Gross Margin Quarter Ended December 31, 2016 Income Before Operating Margin Income Taxes Income Tax Expense Diluted EPS 1 GAAP Basis 47.7% 7.9% $ 30.8 $ (57.5) $ % 8.8% $ 35.3 $ 11.8 $ 0.36 Adjustments: Acquisition and integration costs - 0.4% % Acquisition-related intangible asset amortization - 4.0% % Litigation settlements and expenses - 0.6% Special charges - 2.0% % Tax law changes (0.89) (2.2) 0.03 Gain on disposition - - (1.0) - (0.01) - - (1.0) (0.4) (0.01) Adjusted Basis 47.7% 14.7% $ 76.4 $ 14.6 $ % 14.6% $ 71.6 $ 21.6 $ Total does not add due to rounding. Page 28
29 Gross Margin Year to Date Ended September 30, 2017 Income Operating Margin 1 Before Income Taxes Income Tax Expense Diluted EPS Gross Margin Year to Date Ended September 30, 2016 Income Operating Margin Before Income Taxes Income Tax Expense Diluted EPS 1 GAAP Basis 48.1% 10.0% $ $ 50.7 $ % 8.7% $ $ 15.5 $ 1.86 Adjustments: Acquisition and integration costs 0.2% 0.9% % 1.5% Acquisition-related intangible asset amortization - 4.0% % Field corrective actions (0.2) (0.1) - Litigation settlements and expenses % (9.4) (3.4) (0.09) Special charges - 1.9% % Foreign tax law change (2.2) 0.03 Foreign valuation allowance (0.29) Debt refinancing Gain on disposition - - (1.0) (0.4) (0.01) - - (10.1) (3.7) (0.10) Adjusted Basis 48.3% 16.3% $ $ 98.7 $ % 15.3% $ $ 92.3 $ Total does not add due to rounding. Page 29
30 Appendix Other Supplementary Schedules
31 ($ in millions) Q Revenue Q Revenue Reported Growth Constant Currency Growth Other PSS U.S. $248.4 $243.6 (1.9%) (1.9%) OUS $86.8 $ % (2.0%) Total $335.2 $334.4 (0.2%) (1.9%) CWS & Patient Handling $1,424M FY 2017 Rental & Service MedSurg Beds Specialty Beds Frames & Surfaces Clinical Workflow Solutions Patient Handling Diversified Portfolio Drives Stable, Long-Term Growth Page 31
32 ($ in millions) Q Revenue Q Revenue Reported Growth Constant Currency Growth U.S. $147.7 $ % +7.1% OUS $54.1 $ % +17.0% Total $201.8 $ % +9.8% Respiratory Other FLC $885M FY 2017 Thermometry & Blood Pressure Physical Assessment Vital Signs Physical Assessment Vital Signs Respiratory Care Significant Opportunity To Drive Commercial Value And Innovation Page 32
33 ($ in millions) Q Revenue Q Revenue Reported Growth Constant Currency Growth Blades & Scalpels U.S. $50.0 $ % +1.8% OUS $50.4 $ % +9.7% Total $100.4 $ % +5.8% Other OR Consumables $435M FY 2017 OR Tables & Lights Patient Positioning OR Booms, Pendants & Other Operating Tables Operating Lights Consumables Accelerating Long-Term Global Growth Of Strong, Innovative Portfolio Page 33
Second Quarter 2018 Financial Results. April 27, 2018
Second Quarter 2018 Financial Results April 27, 2018 This presentation contains forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995. All statements included
More informationThird Quarter 2018 Financial Results. July 27, 2018
Third Quarter 2018 Financial Results July 27, 2018 This presentation contains forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995. All statements included
More informationHill-Rom Fourth Quarter 2016 Financial Results. November 3, 2016
Hill-Rom Fourth Quarter 2016 Financial Results November 3, 2016 Forward Looking Statements Certain statements in this presentation contain forward-looking statements, within the meaning of the Private
More informationJ.P. Morgan Healthcare Conference
J.P. Morgan Healthcare Conference John J. Greisch, President and CEO January 9, 2018 This presentation contains forward-looking statements, within the meaning of the Private Securities Litigation Reform
More informationUBS Healthcare Conference John J. Greisch, President and CEO. May 22, 2017
UBS Healthcare Conference John J. Greisch, President and CEO May 22, 2017 Forward Looking Statements This presentation contains forward-looking statements, within the meaning of the Private Securities
More informationADVANCING CONNECTED CARE
ADVANCING CONNECTED CARE J.P. Morgan Healthcare Conference John Groetelaars, President and CEO January 8, 2019 Forward looking statements and non-gaap financial measures This presentation contains forward-looking
More informationHill-Rom Reports Strong Fiscal Third Quarter 2018 Financial Results
NEWS RELEASE Hill-Rom Reports Strong Fiscal Third Quarter 2018 Financial Results 7/27/2018 New Products and Operational Execution Drive Revenue and Margin Expansion; Core Revenue Growth Accelerates Company
More informationMedia Howard Karesh, Vice President, Corporate Communications Phone:
CONTACT INFORMATION Investor Relations Contact: Mary Kay Ladone, Vice President, Investor Relations Phone: 312-819-9387 Email: MaryKay.Ladone@hill-rom.com Media Contact: Howard Karesh, Vice President,
More informationHill-Rom Highlights Long-Term Strategic And Financial Objectives
NEWS RELEASE Hill-Rom Highlights Long-Term Strategic And Financial Objectives 11/3/2017 2020 Outlook Reflects Value of Diversification and Innovation, Portfolio and Business Optimization Initiatives, and
More informationFOURTH QUARTER 2017 EARNINGS CALL FEBRUARY 27, 2018
FOURTH QUARTER 2017 EARNINGS CALL FEBRUARY 27, 2018 0 Agenda and Speakers Joe Woody Chief Executive Officer Halyard Outlook and Update on Divestiture 2018 Priorities Steve Voskuil Chief Financial Officer
More informationWatts Water Technologies 3Q 2017 Earnings Conference Call November 2, 2017
Watts Water Technologies 3Q 2017 Earnings Conference Call November 2, 2017 2017 Watts Water Technologies, Inc. Forward Looking Statements Certain statements in this presentation constitute forward-looking
More informationJ.P. MORGAN HEALTHCARE CONFERENCE. Joe Woody Chief Executive Officer
J.P. MORGAN HEALTHCARE CONFERENCE Joe Woody Chief Executive Officer 0 OVERVIEW FORWARD-LOOKING INFORMATION Certain matters in this presentation and webcast, including our outlook, expectations and planning
More informationJ.P. MORGAN HEALTHCARE CONFERENCE. Robert Abernathy Chairman and CEO
J.P. MORGAN HEALTHCARE CONFERENCE Robert Abernathy Chairman and CEO OVERVIEW FORWARD-LOOKING INFORMATION Certain matters in this presentation and conference call, including our 2016 outlook, expectations
More information1st Quarter 2018 Earnings Conference Call. April 24, 2018
1st Quarter 2018 Earnings Conference Call April 24, 2018 Forward-looking statements During this presentation, we make certain forward-looking statements concerning plans and expectations for Carlisle Companies
More informationOverview Presentation to Investors. February 2016
Overview Presentation to Investors February 2016 Forward-Looking Statements Statements about future results made in this presentation constitute forward-looking statements within the meaning of the Private
More informationWatts Water Technologies 4Q and FY 2017 Earnings Conference Call
Watts Water Technologies 4Q and FY 2017 Earnings Conference Call February 13, 2018 Forward Looking Statements Certain statements in this presentation constitute forward-looking statements within the meaning
More informationFIRST QUARTER 2018 EARNINGS CALL MAY 2, 2018
FIRST QUARTER 2018 EARNINGS CALL MAY 2, 2018 0 Agenda and Speakers Joe Woody Chief Executive Officer Halyard Outlook Update on 2018 Priorities Steve Voskuil Chief Financial Officer First Quarter Financial
More informationCDW Corporation. Webcast Conference Call May 4, CDW.com
CDW Corporation Webcast Conference Call May 4, 2016 CDW.com 800.800.4239 Today's Agenda 1st Quarter Results Key Performance Drivers and Strategic Progress Financial Results Outlook Q&A 1 Disclaimers This
More informationFirst-Quarter 2018 Earnings
First-Quarter 208 Earnings Baxter International Inc. April 26, 208 Safe Harbor Statement This presentation includes forward-looking statements concerning Baxter s financial results, business development
More information2018 FOURTH QUARTER EARNINGS CALL
NORTH AMERICA S LEADING BUILDING MATERIALS DISTRIBUTOR RESIDENTIAL COMMERCIAL INTERIOR SOLAR 2018 FOURTH QUARTER EARNINGS CALL Forward Looking Statements / Non-GAAP Measures This presentation contains
More information4Q17 EARNINGS PRESENTATION NYSE: DOOR
4Q17 EARNINGS PRESENTATION NYSE: DOOR Safe Harbor / Non-GAAP Financial Measures SAFE HARBOR / FORWARD LOOKING STATEMENT This investor presentation contains forward-looking information and other forward-looking
More informationTransUnion. Investor Presentation
TransUnion Investor Presentation APRIL 2017 Disclaimer This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements
More informationPTC PREPARED REMARKS FOURTH QUARTER AND FULL YEAR FISCAL 2017 OCTOBER 25, 2017
PTC PREPARED REMARKS FOURTH QUARTER AND FULL YEAR FISCAL 2017 OCTOBER 25, 2017 Please refer to the Important Disclosures section of these prepared remarks for important information about our operating
More informationIBM 1Q 2018 Earnings. April 17, ibm.com/investor
IBM 1Q 2018 Earnings April 17, 2018 ibm.com/investor Forward Looking Statements and Non-GAAP Information 2 Certain comments made in this presentation may be characterized as forward looking under the Private
More information2016 Financial Update and 2017 Outlook. Webcast Presentation December 13, 2016
2016 Financial Update and 2017 Outlook Webcast Presentation December 13, 2016 Safe Harbor Statement Note: All statements made herein that are not historical facts should be considered as forwardlooking
More informationQ Results Supplemental Presentation to Earnings Press Release May 1, 2018
Q1 2018 Results Supplemental Presentation to Earnings Press Release May 1, 2018 Forward-Looking Statements NuVasive, Inc. ( NuVasive, NUVA or the Company ) cautions you that statements included in this
More informationSyneos Health. Q Financial Results. August 2, 2018
Syneos Health Q2 2018 Financial Results August 2, 2018 Forward-Looking Statements, Non-GAAP Financial Measures, and Basis of Financial Presentation Forward-Looking Statements Except for historical information,
More informationPTC SECOND QUARTER FISCAL 2017 PREPARED REMARKS APRIL 19, 2017
PTC SECOND QUARTER FISCAL 2017 PREPARED REMARKS APRIL 19, 2017 Please refer to the Important Disclosures section of these prepared remarks for important information about our operating metrics (including
More informationQuarterly Investor Presentation. First Quarter 2017
Quarterly Investor Presentation First Quarter 2017 Forward Looking Statements This presentation contains statements about future events and expectations that constitute forward looking statements. These
More informationSECOND QUARTER 2017 EARNINGS CALL AUGUST 2, 2017
SECOND QUARTER 2017 EARNINGS CALL AUGUST 2, 2017 SECOND QUARTER EARNINGS CALL AGENDA CEO Transition Robert Abernathy Chairman Strategic Vision Joe Woody Chief Executive Officer Second Quarter Results and
More informationFourth Quarter 2017 Earnings
Fourth Quarter 2017 Earnings Jeff Jacobson, CEO Bill Osbourn, CFO January 31, 2018 http://www.xerox.com/investor Cautionary Statement Regarding Forward-Looking Statements This presentation, and other written
More informationINC Research Q4 & Full Year 2016 Financial Results. February 28, 2017
INC Research Q4 & Full Year 2016 Financial Results February 28, 2017 Forward Looking Statements & Non-GAAP Financial Measures Forward-Looking Statements Except for historical information, all of the statements,
More information2Q 2017 Highlights and Operating Results
2Q 2017 Highlights and Operating Results July 25, 2017 1 2Q 2017 Highlights and Operating Results Table of Contents Page(s) 1 Sales Overview and Highlights 4-5 2 NSS Overview 6-7 3 EES Overview 8-9 4 UPS
More informationEarnings Call Presentation
Exhibit 99.2 February 27, 2017 Earnings Call Presentation 4 th Quarter 2016 Safe Harbor Statement 2 Our disclosures in this presentation, including without limitation, those relating to future financial
More informationFirst Quarter 2017 Earnings Call Presentation. April 26, 2017
First Quarter 2017 Earnings Call Presentation April 26, 2017 1 Forward-Looking Statements / Safe Harbor This presentation contains forward-looking statements, including statements regarding the proposed
More informationZEBRA TECHNOLOGIES FIRST QUARTER 2016 RESULTS May 10, 2016
ZEBRA TECHNOLOGIES FIRST QUARTER 2016 RESULTS May 10, 2016 Anders Gustafsson Chief Executive Officer Mike Smiley Chief Financial Officer 2 Safe Harbor Statement Statements made in this presentation which
More informationGardner Denver Third Quarter 2017 Earnings Presentation. October 26, 2017
Gardner Denver Third Quarter 2017 Earnings Presentation October 26, 2017 Replay Information Dial toll-free: +1.877.344.7529 International: +1.412.317.0088 Conference ID: #10113255 Log on to: http://investors.gardnerdenver.com
More informationThird Quarter 2018 Earnings Call November 2, 2018
Third Quarter 2018 Earnings Call November 2, 2018 Forward-Looking Statements This supplemental information contains forward-looking statements within the meaning of the Private Securities Litigation Reform
More informationREXNORD Fourth Quarter 2016 Earnings Release May 19, 2016
REXNORD Fourth Quarter 2016 Earnings Release May 19, 2016 Replay Information Domestic toll-free: (888) 843-7419 International toll-free: (630) 652-3042 Access code: 4240 9218# 2 Cautionary Statement Under
More informationSENSATA SECOND QUARTER 2017 EARNINGS PRESENTATION JULY 25, 2017
SENSATA SECOND QUARTER 2017 EARNINGS PRESENTATION JULY 25, 2017 Forward-Looking Statements In addition to historical facts, this earnings presentation, including any documents incorporated by reference
More informationFOURTH QUARTER 2017 EARNINGS CALL //// MARCH 1, 2018
FINISHING COMPONENTS SEATING ACOUSTICS FOURTH QUARTER 2017 EARNINGS CALL //// MARCH 1, 2018 Brian Kobylinski, Chief Executive Officer Chad Paris, Chief Financial Officer Rachel Zabkowicz, Vice President,
More informationFinancial Overview and Model
Financial Overview and Model / John Morici Chief Financial Officer / New York, May 23, 2018 2018 Align Technology, Inc. 1 Forward Looking Statement During this presentation and corresponding commentary
More informationEarnings Presentation October 25, 2018
nvent Third Quarter 2018 Earnings Presentation October 25, 2018 Forward-Looking Statement CAUTION CONCERNING FORWARD-LOOKING STATEMENTS This presentation contains statements that we believe to be "forward-looking
More informationAllegion Second-Quarter 2018 Results. July 26, 2018
Allegion Second-Quarter 2018 Results July 26, 2018 Safe Harbor This presentation contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including
More informationInvestor Presentation
Feb Investor Presentation 2018 Lee D. Rudow President and CEO Michael J. Tschiderer Chief Financial Officer NASDAQ: TRNS 1 Safe Harbor Statement This presentation contains forward looking statements within
More information1Q 2013 INVESTOR PRESENTATION
1Q 2013 INVESTOR PRESENTATION APRIL 2013 FORWARD-LOOKING STATEMENTS The following discussion contains forward-looking statements, including those about Nielsen s outlook and prospects, in the meaning of
More informationCRANE CO. FINANCIAL OVERVIEW
CRANE CO. FINANCIAL OVERVIEW RICHARD MAUE CHIEF FINANCIAL OFFICER 1 Financial Overview 2016 Results 2017 Outlook Free Cash Flow and Capital Deployment Long Term Outlook 2 2016 Operating Results ($ Millions,
More informationSuccessful Execution of Business Transformation Driving Sustainable Growth
Successful Execution of Business Transformation Driving Sustainable Growth Fourth Quarter and Full-Year Fiscal 2017 Conference Call November 16, 2017 Preliminary Statements Forward Looking Statements This
More informationRaymond James Annual Investors Conference
Citi Investor Relations Raymond James Annual Investors Conference March 2, 2015 John Gerspach Chief Financial Officer Highlights Stronger, simpler and safer institution Compact balance sheet with strong
More informationThe J. M. Smucker Company
The J. M. Smucker Company Second Quarter Fiscal 2019 Earnings SUPPLEMENTARY INFORMATION November 28, 2018 Consolidated Results ($ in millions, except per share data) FY19 Q2 FY18 Q2 YoY Change Net Sales
More informationIDEAS East Coast Conference
May 18, 2017 IDEAS East Coast Conference Lee D. Rudow President and CEO Michael J. Tschiderer Chief Financial Officer 1 Safe Harbor Statement This presentation contains forward-looking statements within
More informationMSCI. J.P. Morgan Global High Yield & Leveraged Finance Conference Kathleen Winters, CFO. February 28, 2017
MSCI J.P. Morgan Global High Yield & Leveraged Finance Conference Kathleen Winters, CFO February 28, 2017 2017 MSCI Inc. All rights reserved. Please refer to the disclaimer at the end of this document.
More informationSyneos Health. Q4 and Full Year 2017 Financial Results. February 28, 2018
Syneos Health Q4 and Full Year 2017 Financial Results February 28, 2018 Forward-Looking Statements & Non-GAAP Financial Measures Forward-Looking Statements Except for historical information, all of the
More information2Q 2017 Earnings Presentation. August 8, 2017
2Q 2017 Earnings Presentation August 8, 2017 Caution Concerning Forward-Looking Statements and Non-GAAP Financial Measures This presentation contains forward-looking statements within the meaning of the
More informationIllumina Q Financial Results April 25, Illumina, Inc. All rights reserved.
Illumina Q1 2017 Financial Results April 25, 2017 2017 Illumina, Inc. All rights reserved. Safe Harbor Statement This communication may contain statements that are forward-looking. Forward-looking statements
More informationFirst Quarter 2018 Conference Call
First Quarter 2018 Conference Call Investor Presentation St. Paul, MN March 29, 2018 Safe Harbor & Regulation G 2 Safe Harbor Statement Certain matters discussed today may include 'forward looking statements'
More informationEnergizer Investor Call. November 15, 2018
Energizer Investor Call November 15, 2018 Cautionary Note Regarding Forward- Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation
More informationOur Transformation Continues. March 21, 2018
Our Transformation Continues March 21, 2018 Disclosure Regarding Forward-Looking Statements Forward-Looking Statements and Factors That May Affect Future Results: Throughout this presentation, we make
More informationMcKesson Corporation Fiscal 2018 Financial Performance Fiscal 2019 Annual Outlook. Financial Results and Company Highlights May 24, 2018
McKesson Corporation Fiscal 2018 Financial Performance Fiscal 2019 Annual Outlook Financial Results and Company Highlights Forward-Looking Statements Some of the information in this presentation is not
More informationGardner Denver Q Earnings Presentation. April 27, 2018
Gardner Denver Q1 2018 Earnings Presentation April 27, 2018 Replay Information Dial toll-free: +1.877.344.7529 International: +1.412.317.0088 Conference ID: #10119481 Log on to: http://investors.gardnerdenver.com
More informationSafe Harbor and Non-GAAP Measures
Safe Harbor and Non-GAAP Measures Forward-Looking Statements This presentation contains statements about future events and expectations that constitute forward-looking statements. Forward-looking statements
More informationEarnings Call Presentation
Exhibit 99.2 May 1, 2017 Earnings Call Presentation 1 st Quarter 2017 Safe Harbor Statement 2 Our disclosures in this presentation, including without limitation, those relating to future financial results
More informationHertz Investor Presentation. November 5, 2013 Citi North American Credit Conference New York City, NY
Hertz Investor Presentation November 5, 2013 Citi North American Credit Conference New York City, NY Forward-Looking Statements Certain statements contained in this presentation are forward-looking statements
More informationFINANCIALS VINCENT PILETTE CFO
FINANCIALS VINCENT PILETTE CFO FORWARD-LOOKING STATEMENTS This presentation includes forward-looking statements within the meaning of the U.S. federal securities laws, including, without limitation, statements
More informationInvestor Presentation. Second Quarter 2018 NASDAQ: BECN BECN
Investor Presentation Second Quarter 2018 BECN 1 Disclosures Forward Looking Statements and Non-GAAP Measures This presentation contains forward-looking statements within the meaning of the Private Securities
More informationEndo International plc
Endo International plc Q2 2015 Earnings Report August 10, 2015 Forward Looking Statements; Non-GAAP Financial Measures This presentation contains forward-looking statements within the meaning of the Private
More informationXYLEM INC. Q EARNINGS RELEASE FEBRUARY 1, 2018
XYLEM INC. Q4 2017 EARNINGS RELEASE FEBRUARY 1, 2018 Q4 2017 EARNINGS RELEASE FORWARD-LOOKING STATEMENTS This presentation contains information that may constitute forward-looking statements. Forward-looking
More informationMSCI THIRD QUARTER 2016
MSCI THIRD QUARTER 2016 Earnings Presentation October 27, 2016 2016 MSCI Inc. All rights reserved. Please refer to the disclaimer at the end of this document. FORWARD-LOOKING STATEMENTS Forward-Looking
More informationFourth Quarter and Full Year 2018 Financial Review and Analysis
Fourth Quarter and Full Year 2018 Financial Review and Analysis (preliminary, unaudited) Supplemental Presentation Materials Unless otherwise indicated, comparisons are to the same periods in the prior
More informationMcCormick & Company, Inc. 4th Quarter 2018 Financial Results and 2019 Outlook
McCormick & Company, Inc. 4th Quarter 2018 Financial Results and 2019 Outlook January 24 th 2019 The following slides accompany a January 24 th 2019, earnings release conference call. This information
More informationInvestor Update Philip Mezey, President and Chief Executive Officer
Investor Update Philip Mezey, President and Chief Executive Officer Barbara Doyle, Vice President, Investor Relations March 2018 FORWARD LOOKING STATEMENTS Certain matters in this presentation and being
More informationQ Earnings Call February 20, 2019
Q4 2018 Earnings Call February 20, 2019 1 Forward-looking statements Safe Harbor Statement This release contains forward-looking statements, which may concern our plans, objectives, outlook, goals, strategies,
More informationForward-Looking Statements
William Blair & Company 27 th Annual Growth Stock Conference June 20, 2007 0 Forward-Looking Statements This presentation contains forward-looking statements that are subject to a number of risks and uncertainties,
More informationSingular Best of the Uncovered 12 th Annual Conference 2017
Dec 4, 2017 Singular Best of the Uncovered 12 th Annual Conference 2017 Michael J. Tschiderer Chief Financial Officer NASDAQ: TRNS 1 Safe Harbor Statement This presentation contains forward-looking statements
More informationFINANCIAL OVERVIEW AL MISTYSYN SENIOR VICE PRESIDENT, FINANCE & CHIEF FINANCIAL OFFICER FINANCIAL COMMUNITY PRESENTATION OCTOBER 3, 2017
FINANCIAL OVERVIEW AL MISTYSYN SENIOR VICE PRESIDENT, FINANCE & CHIEF FINANCIAL OFFICER FINANCIAL COMMUNITY PRESENTATION OCTOBER 3, 2017 Forward Looking Statement The presentations today will contain certain
More information3rd Quarter 2018 Earnings Conference Call. October 23, 2018
3rd Quarter 2018 Earnings Conference Call October 23, 2018 Forward-looking statements During this presentation, we make certain forward-looking statements concerning plans and expectations for Carlisle
More informationQ Supplemental Financial Information. February 1, 2018
February 1, 2018 This presentation may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements relate to future events or our future
More informationRelated to Forward-Looking Statements Related to Non-GAAP Financial Information
Q2 2017 Earnings Disclaimers Related to Forward-Looking Statements Certain items in this presentation and in today s discussion, including matters relating to revenue, net income (loss), and percentages
More informationFourth Quarter 2018 Earnings Review
Citi Investor Relations Fourth Quarter 2018 Earnings Review January 14, 2019 Overview 4Q 18 showed continued progress in a challenging environment Continued momentum in Institutional accrual businesses
More informationSENSATA THIRD QUARTER 2017 EARNINGS PRESENTATION OCTOBER 24, 2017
SENSATA THIRD QUARTER 2017 EARNINGS PRESENTATION OCTOBER 24, 2017 Forward-Looking Statements In addition to historical facts, this earnings presentation, including any documents incorporated by reference
More information2017 Investment Community Meeting. Moving With Speed
2017 Investment Community Meeting Moving With Speed Brett Biggs Walmart Finance Walmart uniquely positioned to win Win with customers Win with shareholders Update on expectations Financial strength Financial
More information4Q 2018 Highlights and Operating Results. Products. Technology. Services. Delivered Globally.
4Q 2018 Highlights and Operating Results Products. Technology. Services. Delivered Globally. Table of Contents Page 3 Safe Harbor Statement and Non-GAAP Financial Measures 4 Sales Overview 9 Overview of
More information4Q 2017 Presentation. February 27, 2018
4Q 2017 Presentation February 27, 2018 SAFE HARBOR Statements contained in this presentation that are not historical and reflect our views about future periods and events, including our future performance,
More informationQ EARNINGS CONFERENCE CALL BILL NUTI, CHAIRMAN & CEO MARK BENJAMIN, PRESIDENT & COO BOB FISHMAN, CFO
1 Q2 2017 EARNINGS CONFERENCE CALL BILL NUTI, CHAIRMAN & CEO MARK BENJAMIN, PRESIDENT & COO BOB FISHMAN, CFO July 20, 2017 NOTES TO INVESTORS FORWARD-LOOKING STATEMENTS. Comments made during this conference
More informationEarnings Webcast & Conference Call
EXHIBIT 99.2 August 7, 2015 Earnings Webcast & Conference Call Fourth Quarter and Fiscal Year 2015 2014 1 Forward-Looking Statements This presentation and other written or oral statements made from time
More informationCautionary Statement Regarding Forward-Looking Statements
January 2018 Cautionary Statement Regarding Forward-Looking Statements Forward Looking Statements: Certain statements are forward-looking statements made pursuant to the safe harbor provisions of the Private
More informationDAVE MARBERGER CHIEF FINANCIAL OFFICER
1 DAVE MARBERGER CHIEF FINANCIAL OFFICER 2 DAVE MARBERGER CHIEF FINANCIAL OFFICER With Conagra since 2016 Previous Experience Prestige Brands: 1 year Godiva Chocolatier: 7 years Tasty Baking Company: 5
More informationFourth-Quarter Fiscal 2018 Earnings
Fourth-Quarter Fiscal 2018 Earnings Sam Mitchell, CEO Mary Meixelsperger, CFO Sean Cornett, Director of Investor Relations November 6, 2018 http://investors.valvoline.com Forward-Looking Statements Certain
More informationResults for Q4 FY2014 (Quarter Ended March 31, 2014) Earnings Announcement: April 30, 2014
Results for Q4 FY2014 (Quarter Ended March 31, 2014) Earnings Announcement: April 30, 2014 Risks and Non-GAAP Disclosures This presentation contains forward-looking statements, which are based on current
More information4Q Fiscal 2018 ADP Earnings Call & Webcast
4Q Fiscal 2018 ADP Earnings Call & Webcast August 1, 2018 Forward Looking Statements This presentation and other written or oral statements made from time to time by ADP may contain forwardlooking statements
More informationCRANE CO. FINANCIAL OVERVIEW
CRANE CO. FINANCIAL OVERVIEW RICHARD MAUE CHIEF FINANCIAL OFFICER 1 Financial Overview 2017 Results 2018 Outlook Multi-Year Outlook Capital Deployment 2 2017 Operating Results ($ Millions, Except per Share
More informationFOURTH QUARTER 2015 EARNINGS CALL. February 29, 2016
FOURTH QUARTER 2015 EARNINGS CALL February 29, 2016 FOURTH QUARTER EARNINGS CALL AGENDA Fourth Quarter Update Robert Abernathy, Chairman and Chief Executive Officer Fourth Quarter Results and 2016 Outlook
More information\\intranet.barcapint.com\dfs-amer\group\nyk\area\ibd\industrial\companies\jeld-wen\ Project Jamaica Dual Track\ IPO
\\intranet.barcapint.com\dfs-amer\group\nyk\area\ibd\industrial\companies\jeld-wen\2015.07 Project Jamaica Dual Track\2015.10 IPO Execution\Presentation\Roadshow Presentation\Project Falcon_Roadshow Presentation_(1.13.17)_vNear
More informationMondelēz International Q Results. July 27, 2016
Mondelēz International Q2 2016 Results July 27, 2016 1 Forward-Looking Statements This presentation contains a number of forward-looking statements. Words, and variations of words, such as will, expect,
More informationInvestor Deck December 2018
Investor Deck December 2018 Safe Harbor This presentation includes forward-looking statements which are statements that are not historical facts, including statements that relate to the mix of and demand
More informationZEBRA TECHNOLOGIES SECOND-QUARTER 2016 RESULTS. August 9, 2016
ZEBRA TECHNOLOGIES SECOND-QUARTER 2016 RESULTS August 9, 2016 Anders Gustafsson Chief Executive Officer Mike Smiley Chief Financial Officer 2 Safe Harbor Statement Statements made in this presentation
More information2Q 2015 Earnings Call. August 11, :00am ET
2Q 2015 Earnings Call August 11, 2015 8:00am ET Safe Harbor Statement Certain statements made within this presentation contain forward-looking statements, within the meaning of the Private Securities Litigation
More informationOur Transformation Continues Sidoti NDR May 29-30, 2018
Our Transformation Continues Sidoti NDR May 29-30, 2018 Disclosure Regarding Forward-Looking Statements Forward-Looking Statements and Factors That May Affect Future Results: Throughout this presentation,
More informationPTC PREPARED REMARKS SECOND QUARTER FISCAL 2018 APRIL 18, 2018
PTC PREPARED REMARKS SECOND QUARTER FISCAL 2018 APRIL 18, 2018 Please refer to the Important Disclosures section of these prepared remarks for important information about our operating metrics (including
More informationStryker. Kevin A. Lobo Chairman and Chief Executive Officer
Stryker Kevin A. Lobo Chairman and Chief Executive Officer Disclaimer Forward-looking statement This presentation contains information that includes or is based on forward looking statements within the
More information